Feedback / Questions
BMF-500 - Biomea Fusion
https://www.globenewswire.com/news-release/2024/12/06/2993010/0/en/Biomea-Fusion-to-Host-Conference-Call-to-Present-initial-Clinical-Data-from-Phase-I-COVALENT-103-Study-of-BMF-500-a-Covalent-FLT3-Inhibitor-in-Relapsed-or-Refractory-Acute-Leukemia.html
Dec 6, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next